AVE 33.3% 0.2¢ avecho biotechnology limited

Chart, Cash and Scenarios, page-25

  1. 5,322 Posts.
    Im Gobsmacked that anyone would think POH was trying to partner its OxyC patch in 2011 ( at a time when it hadn't even optimised its patch) and then make derisory comments that it couldn't find a partner. I don't recall POH ever making statements other than it expects to license after Phase 2.
 
watchlist Created with Sketch. Add AVE (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.